Skip to main content
Oncotarget logoLink to Oncotarget
. 2019 Mar 15;10(22):2236. doi: 10.18632/oncotarget.26807

Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma

Roelants Caroline 1,2, Giacosa Sofia 1, Pillet Catherine 3, Bussat Remi 1, Champelovier Pierre 4, Bastien Olivier 5, Guyon Laurent 1, Arnoux Valentin 4, Cochet Claude 1, Filhol Odile 1
PMCID: PMC6481339  PMID: 31040915

This article has been corrected: The correct author information is given below:

Roelants Caroline1,2, Giacosa Sofia1, Pillet Catherine3, Bussat Rémi1, Champelovier Pierre4, Bastien Olivier5, Guyon Laurent1, Arnoux Valentin4, Cochet Claude1 and Filhol Odile1

Original article: Oncotarget. 2018; 9:30066-30078. https://doi.org/10.18632/oncotarget.25700


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES